Perceptions and Preferences for Defining Biosimilar Products in Prescription Drug Promotion

Perceptions and Preferences for Defining Biosimilar Products in Prescription Drug Promotion

Mihaela Johnson, Jessica E. Thompson, Avery A. Tilley, Amie C. O’Donoghue, Kathryn J. Aikin

The Journal of the American Board of Family Medicine Jan 2025, 38 (1) 94-106; DOI: 10.3122/jabfm.2024.240151R1

Comments (0)

No login
gif